Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line
- PMID: 2422205
- PMCID: PMC362827
- DOI: 10.1128/jcm.23.4.737-742.1986
Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line
Abstract
We developed cloned populations from the commonly available, well-characterized cell line HUT-78. These cloned cells grow permanently after infection with isolates of human T-lymphotropic virus type III, also called lymphadenopathy virus (HTLV-III/LAV), from patients with acquired immune deficiency syndrome and related syndromes. In contrast, activated human T cells are lysed after HTLV-III/LAV infection. The infected cloned cells have been in culture continuously for 6 months and have produced high levels of extracellular reverse transcriptase (400,000 cpm/ml). This level is comparable to that of similarly infected normal human T cells. Three weeks after infection with HTLV-III/LAV, more than 90% of the cloned HUT-78 cells lysed; the remaining cells continued to grow. Approximately 80% of these cells expressed HTLV-III/LAV antigens by immunofluorescence. The extracellular virus of the chronically infected cell line was shown to be similar to other HTLV-III/LAV isolates by competition radioimmunoassay, by reactivity with human serum, and by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This HTLV-III/LAV-infected immortalized cell line enables the continuous production of large amounts of virus.
Similar articles
-
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).Science. 1986 Apr 11;232(4747):238-43. doi: 10.1126/science.3006256. Science. 1986. PMID: 3006256
-
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.Science. 1984 May 4;224(4648):497-500. doi: 10.1126/science.6200935. Science. 1984. PMID: 6200935
-
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.J Immunol. 1986 May 15;136(10):3619-24. J Immunol. 1986. PMID: 2422259
-
Immunopathogenesis of the acquired immunodeficiency syndrome.Ann Intern Med. 1985 Nov;103(5):704-9. doi: 10.7326/0003-4819-103-5-704. Ann Intern Med. 1985. PMID: 2996403 Review.
-
Etiology of AIDS: biological and biochemical characteristics of HTLV-III.Adv Exp Med Biol. 1985;187:13-34. doi: 10.1007/978-1-4615-9430-7_2. Adv Exp Med Biol. 1985. PMID: 2994417 Review.
Cited by
-
A time-of-drug addition approach to target identification of antiviral compounds.Nat Protoc. 2011 Jun;6(6):925-33. doi: 10.1038/nprot.2011.330. Epub 2011 Jun 2. Nat Protoc. 2011. PMID: 21637207 Free PMC article.
-
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.J Virol. 1997 Jun;71(6):4319-30. doi: 10.1128/JVI.71.6.4319-4330.1997. J Virol. 1997. PMID: 9151820 Free PMC article.
-
Heterosexual and perinatal transmission of human immunodeficiency virus in a low prevalence community.West J Med. 1988 Feb;148(2):171-5. West J Med. 1988. PMID: 3348026 Free PMC article.
-
Significance of premature stop codons in env of simian immunodeficiency virus.J Virol. 1989 Nov;63(11):4709-14. doi: 10.1128/JVI.63.11.4709-4714.1989. J Virol. 1989. PMID: 2795718 Free PMC article.
-
Antigen-antibody reaction in solution in capture competition immunoassay for human immunodeficiency virus antibodies.J Clin Microbiol. 1989 Jul;27(7):1609-12. doi: 10.1128/jcm.27.7.1609-1612.1989. J Clin Microbiol. 1989. PMID: 2768447 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources